Sojeong Park

Sojeong Park

Auto-generated profile, based on publicly available information

Sojeong Park

Department of Data Science, Hanmi Pharm. Co., Ltd., Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2022 in Clinics in Orthopedic Surgery
Verified
Journal Article
Open access
PDF file
JPJung-Wee Park
Jung-Wee Park
HKHong Seok Kim
Hong Seok Kim
SPSojeong Park
Sojeong Park
SKSung Hwa Kim
Sung Hwa Kim
YLYoung-kyun Lee
Young-kyun Lee
KKKyung-Hoi Koo
Kyung-Hoi Koo
Park JW, et al. Clin Orthop Surg. 2022 Sep;14:e69. https://doi.org/10.4055/cios22027

28 February 2022 in Diabetes Care
Verified
Journal Article
Closed access
PDF file
NLNami Lee
Nami Lee
SPSo Jeong Park
So Jeong Park
DKDongwoo Kang
Dongwoo Kang
JJJa Young Jeon
Ja Young Jeon
HKHae Jin Kim
Hae Jin Kim
SHSeung Jin Han
Seung Jin Han
OBJECTIVE: The natural course of diabetes of the exocrine pancreas (DEP) is not well established. We aimed to compare the risk of insulin initiation, diabetic complications, and mortality between DEP and type 2 diabetes. RESEARCH DESIGN AND METHODS: Using the Korean National Health Insurance Service–Health Screening Cohort between 2012 and 2017, we divided patients with diabetes into those with diabetes without prior pancreatic disease (indicated type 2 diabetes, n = 153,894) and diabetes with a prior diagnosis of pancreatic disease (indicated DEP, n = 3,629). ICD-10 codes and pharmacy prescription information were used to define type 2 diabetes, DEP, and acute and chronic diabetes complications. Kaplan-Meier curves were produced to compare insulin use over time between groups. We created logistic regression models for odds of progression to diabetic complications and mortality. RESULTS: DEP was associated with a higher risk of insulin use than type 2 diabetes (adjusted hazard ratio 1.38 at 5 years [95% CI 1.30–1.47], P < 0.0001). Individuals with DEP showed higher risks of hypoglycemia (odds ratio 1.85 [1.54–2.21], P < 0.0001), diabetic neuropathy (1.38 [1.28–1.49], P < 0.0001), nephropathy (1.38 [1.27–1.50], P < 0.0001), retinopathy (1.10 [1.01–1.20], P = 0.0347), coronary heart disease (1.59 [1.48–1.70], P < 0.0001), cerebrovascular disease (1.38 [1.28–1.49], P < 0.0001), and peripheral arterial disease (1.34 [1.25–1.44], P < 0.0001). All-cause mortality was higher in those with DEP (1.74 [1.57–1.93], P < 0.0001) than in those with type 2 diabetes. CONCLUSIONS: DEP is more likely to require insulin therapy than type 2 diabetes. Hypoglycemia, micro- and macrovascular complications, and all-cause mortality events are higher in DEP compared with type 2 diabetes.

8 July 2021 in Cancers
Verified
Journal Article
Open access
PDF file
HCHo Soo Chun
Ho Soo Chun
SPSojeong Park
Sojeong Park
MLMinjong Lee
Minjong Lee
YCYuri Cho
Yuri Cho
HKHa Sung Kim
Ha Sung Kim
TKTae Hun Kim
Tae Hun Kim
Background and Aims: In the general population, previous studies reported that physical activity was associated with risk of hepatocellular carcinoma (HCC) development. However, it is unclear whether physical activity is associated with risk of HCC development in patients with chronic hepatitis B (CHB). We aimed to elucidate the association between physical activity and risk of HCC development in CHB patients. Methods: This nationwide cohort study involved treatment-naive patients with CHB (n = 9727) who started treatment with entecavir or tenofovir and answered self-reported questionnaires between January 2012 and December 2017, using data from the Korean National Health Insurance Service database. The primary endpoint was development of HCC. Multivariable Cox regression and competing risk analyses were used. Results: During a median follow-up of 3.1 years, cumulative HCC incidence rates were 8.3%. There was an inverse association between physical activity and the risk of HCC (p < 0.001). Patients with 1000–1500 metabolic equivalent task (MET)-min/week, compared to those without physical activity, showed a significantly lower risk of HCC in both patients without cirrhosis (adjusted hazard ratio [aHR] 0.66, p = 0.02) and patients with cirrhosis (aHR 0.61, p = 0.02). In patients who were younger (<60), male, without diabetes, and with high BMI, amounts of physical activity of 1000–1500 MET-min/week showed an inverse association with the risk of HCC (aHR 0.65, 0.63, 0.65, and 0.64, respectively, all p < 0.05). Conclusion: Physical activity was significantly associated with a low risk of HCC in CHB patients treated with entecavir or tenofovir.

3 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
HKHyuk Sung Kwon
Hyuk Sung Kwon
Yong Whi JeongYong Whi Jeong
Yong Whi Jeong
SKSeung hyun Kim
Seung hyun Kim
KPKee Hyung Park
Kee Hyung Park
SSSang Won Seo
Sang Won Seo
HCHojin Choi
Hojin Choi
National dementia plans were applied in dementia support centers established in Seoul, Korea between 2007 and 2009. However, the annual incidence rates of dementia in Seoul have not been reported. We investigated this annual incidence and the characteristics of incident cases from 2003 to 2018. The customized research database of the Korean National Health Insurance Services was used. The annual crude and age-standardized incidence of dementia patients and their characteristics were analyzed. This study analyzed 108,596 incident dementia cases aged ≥60 years. The incidence rate increased from 2003 to 2011, including a rapid increment from 2007 to 2011. From 2011 to 2018, the crude (age-standardized) incidence per 105 person-years decreased from 641.51 (577.12) to 448.26 (361.23). The proportion of incident dementia cases was highest in the highest income group every year. However, the proportion of incident dementia cases in the lowest income group increased from 10.4% in 2003 to 25.8% in 2011. The annual incidence rate of dementia showed a sharp increase immediately after 2007, the year dementia support centers began to be introduced, and then stabilized after 2011. The characteristics of incident dementia cases have changed, including the proportion in the low-income group.

23 August 2025 in Diabetes Research and Clinical Practice
Verified
Journal Article
Closed access
DSDong Woo Shim
Dong Woo Shim
WLWonwoo Lee
Wonwoo Lee
KPKwang Hwan Park
Kwang Hwan Park
YYYeo Kwon Yoon
Yeo Kwon Yoon
MPMinae Park
Minae Park
JLJin Woo Lee
Jin Woo Lee

3 August 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
PLPil Hyung Lee
Pil Hyung Lee
SPSojeong Park
Sojeong Park
HNHyewon Nam
Hyewon Nam
DKDo‐Yoon Kang
Do‐Yoon Kang
SKSoo‐Jin Kang
Soo‐Jin Kang
CLCheol Whan Lee
Cheol Whan Lee
Background: Limited data are available on intracranial hemorrhage (ICH) in patients undergoing antithrombotic therapy after percutaneous coronary intervention (PCI). Methods and Results: Using the Korean National Health Insurance Service database, we identified 219 274 patients without prior ICH and who underwent a first PCI procedure between 2007 and 2016 and analyzed nontraumatic ICH and all‐cause mortality. ICH after PCI occurred in 4171 patients during a median follow‐up of 5.6 years (overall incidence rate: 3.32 cases per 1000 person‐years). The incidence rate of ICH showed an early peak of 21.66 cases per 1000 person‐years within the first 30 days, followed by a sharp decrease to 3.68 cases per 1000 person‐years between 30 days and 1 year, and to <1 case per 1000 patient‐years from the second year until 10 years after PCI. The 1‐year mortality rate was 38.2% after ICH, with most deaths occurring within 30 days (n=999, mortality rate: 24.2%). No significant difference in mortality risk was observed between patients who had ICH within and after 1 year following PCI (adjusted hazard ratio, 1.04; 95% CI, 0.95–1.14; P =0.43). The predictors of post‐PCI ICH were age ≥75 years, hypertension, atrial fibrillation, end‐stage renal disease, history of stroke or transient ischemic attack, dementia, and use of vitamin K antagonists. Conclusions: New ICH most frequently occurs in the early period after PCI and is associated with a high risk of early death, regardless of the occurrence time of ICH. Careful implementation of antithrombotic strategies is needed in patients at an increased risk for ICH, particularly in the peri‐PCI period.